139 related articles for article (PubMed ID: 16777688)
1. Utility of a web-based breast cancer predictive algorithm for adjuvant chemotherapeutic decision making in a multidisciplinary oncology center.
Epstein RJ; Leung TW; Mak J; Cheung PS
Cancer Invest; 2006; 24(4):367-73. PubMed ID: 16777688
[TBL] [Abstract][Full Text] [Related]
2. A decision aid to assist in adjuvant therapy choices for breast cancer.
Siminoff LA; Gordon NH; Silverman P; Budd T; Ravdin PM
Psychooncology; 2006 Nov; 15(11):1001-13. PubMed ID: 16511899
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy for breast cancer: how presentation of recurrence risk influences decision-making.
Chao C; Studts JL; Abell T; Hadley T; Roetzer L; Dineen S; Lorenz D; YoussefAgha A; McMasters KM
J Clin Oncol; 2003 Dec; 21(23):4299-305. PubMed ID: 14581440
[TBL] [Abstract][Full Text] [Related]
4. Decreased use of adjuvant breast cancer therapy in a randomized controlled trial of a decision aid with individualized risk information.
Peele PB; Siminoff LA; Xu Y; Ravdin PM
Med Decis Making; 2005; 25(3):301-7. PubMed ID: 15951457
[TBL] [Abstract][Full Text] [Related]
5. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
[TBL] [Abstract][Full Text] [Related]
6. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
Mariotto AB; Feuer EJ; Harlan LC; Abrams J
J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
[TBL] [Abstract][Full Text] [Related]
7. A computer program to assist in making breast cancer adjuvant therapy decisions.
Ravdin PM
Semin Oncol; 1996 Feb; 23(1 Suppl 2):43-50. PubMed ID: 8614844
[TBL] [Abstract][Full Text] [Related]
8. Factors affecting patients' perceptions of choice regarding adjuvant chemotherapy for breast cancer.
Jansen SJ; Otten W; Stiggelbout AM
Breast Cancer Res Treat; 2006 Sep; 99(1):35-45. PubMed ID: 16541318
[TBL] [Abstract][Full Text] [Related]
9. How important is the axillary nodal status for adjuvant treatment decisions at a breast cancer multidisciplinary tumor board? A survival analysis.
Reimer T; Fietkau R; Markmann S; Stachs A; Gerber B
Ann Surg Oncol; 2008 Feb; 15(2):472-7. PubMed ID: 17987339
[TBL] [Abstract][Full Text] [Related]
10. A computer based program to assist in adjuvant therapy decisions for individual breast cancer patients.
Ravdin PM
Bull Cancer; 1995 Dec; 82 Suppl 5():561s-564s. PubMed ID: 8680066
[TBL] [Abstract][Full Text] [Related]
11. Linking evidence-based medicine therapeutic summary measures to clinical decision analysis.
Djulbegovic B; Hozo I; Lyman GH
MedGenMed; 2000 Jan; 2(1):E6. PubMed ID: 11104452
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer.
Delea TE; Karnon J; Smith RE; Johnston SR; Brandman J; Sung JC; Gross PE
Am J Manag Care; 2006 Jul; 12(7):374-86. PubMed ID: 16834524
[TBL] [Abstract][Full Text] [Related]
13. Improved survival for women with stage I breast cancer in south-east Sweden: a comparison between two time periods before and after increased use of adjuvant systemic therapy.
Johansson P; Fohlin H; Arnesson LG; Dufmats M; Nordenskjöld K; Nordenskjöld B; Stål O;
Acta Oncol; 2009; 48(4):504-13. PubMed ID: 19235568
[TBL] [Abstract][Full Text] [Related]
14. Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.
Viale G; Regan MM; Maiorano E; Mastropasqua MG; Golouh R; Perin T; Brown RW; Kovács A; Pillay K; Ohlschlegel C; Braye S; Grigolato P; Rusca T; Gelber RD; Castiglione-Gertsch M; Price KN; Goldhirsch A; Gusterson BA; Coates AS
J Clin Oncol; 2008 Mar; 26(9):1404-10. PubMed ID: 18349391
[TBL] [Abstract][Full Text] [Related]
15. Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer: a randomised phase III trial of the European Organisation for Research and Treatment of Cancer Breast Group.
Morales L; Canney P; Dyczka J; Rutgers E; Coleman R; Cufer T; Welnicka-Jaskiewicz M; Nortier J; Bogaerts J; Therasse P; Paridaens R; ;
Eur J Cancer; 2007 Jan; 43(2):331-40. PubMed ID: 17134892
[TBL] [Abstract][Full Text] [Related]
16. Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.
Ellis MJ; Tao Y; Luo J; A'Hern R; Evans DB; Bhatnagar AS; Chaudri Ross HA; von Kameke A; Miller WR; Smith I; Eiermann W; Dowsett M
J Natl Cancer Inst; 2008 Oct; 100(19):1380-8. PubMed ID: 18812550
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of international treatment guidelines and prognostic tests for the treatment of early breast cancer.
Muñoz M; Estévez LG; Alvarez I; Fernández Y; Margelí M; Tusquets I; Seguí MA; Lluch A
Cancer Treat Rev; 2008 Dec; 34(8):701-9. PubMed ID: 18922644
[TBL] [Abstract][Full Text] [Related]
18. [Influence of social and cultural patterns on decision-making in oncology].
Soum-Pouyalet F; Regnier V; Querre M; Jacquin JP; Hubert A; Debled M
Bull Cancer; 2009 Jun; 96(6):733-9. PubMed ID: 19473959
[TBL] [Abstract][Full Text] [Related]
19. Preferences for different methods of communicating information regarding adjuvant chemotherapy for breast cancer.
Studts JL; Abell TD; Roetzer LM; Albers AN; McMasters KM; Chao C
Psychooncology; 2005 Aug; 14(8):647-60. PubMed ID: 15580617
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: assessing outcome in a population-based, observational cohort.
Elkin EB; Hurria A; Mitra N; Schrag D; Panageas KS
J Clin Oncol; 2006 Jun; 24(18):2757-64. PubMed ID: 16782916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
